APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Opioid Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchOpioid Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Analgesics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Opioid Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Analgesics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Opioid Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Analgesics include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Analgesics Segment by Company

Assertio Holdings, Inc

Bausch Health

Boehringer Ingelheim International GmbH

Endo International Plc

F. Hoffmann-La Roche AG

Purdue Pharmaceuticals L.P.

Sanofi S.A.

Teva Pharmaceuticals

Abbott Laboratories

Bayer AG

GlaxoSmithKline plc

Pfizer Inc.

Novartis AG

Johnson & Johnson

Opioid Analgesics Segment by Type

Morphine

Methadone

OxyContin

Vicodin

Others

Opioid Analgesics Segment by Application

Surgical Pain

Neuropathic Pain

Cancer Pain

Others

Opioid Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Opioid Analgesics Industry Trends Table 2. Opioid Analgesics Industry Drivers Table 3. Opioid Analgesics Industry Opportunities and Challenges Table 4. Opioid Analgesics Industry Restraints Table 5. Global Opioid Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Opioid Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Opioid Analgesics Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Opioid Analgesics Sales Market Share by Manufacturers Table 9. Global Opioid Analgesics Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Opioid Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Opioid Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Opioid Analgesics Manufacturers, Product Type & Application Table 13. Global Opioid Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Morphine Table 17. Major Manufacturers of Methadone Table 18. Major Manufacturers of OxyContin Table 19. Major Manufacturers of Vicodin Table 20. Major Manufacturers of Others Table 21. Global Opioid Analgesics Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 23. Global Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 24. Global Opioid Analgesics Sales Market Share by Type (2021-2026) Table 25. Global Opioid Analgesics Sales Market Share by Type (2027-2032) Table 26. Global Opioid Analgesics Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 27. Global Opioid Analgesics Revenue by Type (2021-2026) & (Tons) Table 28. Global Opioid Analgesics Revenue by Type (2027-2032) & (Tons) Table 29. Global Opioid Analgesics Revenue Market Share by Type (2021-2026) Table 30. Global Opioid Analgesics Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Surgical Pain Table 32. Major Manufacturers of Neuropathic Pain Table 33. Major Manufacturers of Cancer Pain Table 34. Major Manufacturers of Others Table 35. Global Opioid Analgesics Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 37. Global Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 38. Global Opioid Analgesics Sales Market Share by Application (2021-2026) Table 39. Global Opioid Analgesics Sales Market Share by Application (2027-2032) Table 40. Global Opioid Analgesics Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 41. Global Opioid Analgesics Revenue by Application (2021-2026) & (Tons) Table 42. Global Opioid Analgesics Revenue by Application (2027-2032) & (Tons) Table 43. Global Opioid Analgesics Revenue Market Share by Application (2021-2026) Table 44. Global Opioid Analgesics Revenue Market Share by Application (2027-2032) Table 45. Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Opioid Analgesics Sales by Region (2021-2026) & (Tons) Table 47. Global Opioid Analgesics Sales Market Share by Region (2021-2026) Table 48. Global Opioid Analgesics Sales Forecasted by Region (2027-2032) & (Tons) Table 49. Global Opioid Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 51. North America Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 52. North America Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 53. Europe Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Europe Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 55. Europe Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 56. Asia Pacific Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Asia Pacific Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 58. Asia Pacific Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 59. South America, Middle East and Africa Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 60. South America, Middle East and Africa Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 61. South America, Middle East and Africa Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 62. Global Opioid Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Opioid Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Opioid Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Opioid Analgesics Revenue Market Share by Region (2021-2026) Table 66. Global Opioid Analgesics Revenue Market Share by Region (2027-2032) Table 67. Assertio Holdings, Inc Company Information Table 68. Assertio Holdings, Inc Business Overview Table 69. Assertio Holdings, Inc Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Assertio Holdings, Inc Opioid Analgesics Product Portfolio Table 71. Assertio Holdings, Inc Recent Development Table 72. Bausch Health Company Information Table 73. Bausch Health Business Overview Table 74. Bausch Health Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bausch Health Opioid Analgesics Product Portfolio Table 76. Bausch Health Recent Development Table 77. Boehringer Ingelheim International GmbH Company Information Table 78. Boehringer Ingelheim International GmbH Business Overview Table 79. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio Table 81. Boehringer Ingelheim International GmbH Recent Development Table 82. Endo International Plc Company Information Table 83. Endo International Plc Business Overview Table 84. Endo International Plc Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Endo International Plc Opioid Analgesics Product Portfolio Table 86. Endo International Plc Recent Development Table 87. F. Hoffmann-La Roche AG Company Information Table 88. F. Hoffmann-La Roche AG Business Overview Table 89. F. Hoffmann-La Roche AG Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio Table 91. F. Hoffmann-La Roche AG Recent Development Table 92. Purdue Pharmaceuticals L.P. Company Information Table 93. Purdue Pharmaceuticals L.P. Business Overview Table 94. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio Table 96. Purdue Pharmaceuticals L.P. Recent Development Table 97. Sanofi S.A. Company Information Table 98. Sanofi S.A. Business Overview Table 99. Sanofi S.A. Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sanofi S.A. Opioid Analgesics Product Portfolio Table 101. Sanofi S.A. Recent Development Table 102. Teva Pharmaceuticals Company Information Table 103. Teva Pharmaceuticals Business Overview Table 104. Teva Pharmaceuticals Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Teva Pharmaceuticals Opioid Analgesics Product Portfolio Table 106. Teva Pharmaceuticals Recent Development Table 107. Abbott Laboratories Company Information Table 108. Abbott Laboratories Business Overview Table 109. Abbott Laboratories Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Abbott Laboratories Opioid Analgesics Product Portfolio Table 111. Abbott Laboratories Recent Development Table 112. Bayer AG Company Information Table 113. Bayer AG Business Overview Table 114. Bayer AG Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Bayer AG Opioid Analgesics Product Portfolio Table 116. Bayer AG Recent Development Table 117. GlaxoSmithKline plc Company Information Table 118. GlaxoSmithKline plc Business Overview Table 119. GlaxoSmithKline plc Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. GlaxoSmithKline plc Opioid Analgesics Product Portfolio Table 121. GlaxoSmithKline plc Recent Development Table 122. Pfizer Inc. Company Information Table 123. Pfizer Inc. Business Overview Table 124. Pfizer Inc. Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Pfizer Inc. Opioid Analgesics Product Portfolio Table 126. Pfizer Inc. Recent Development Table 127. Novartis AG Company Information Table 128. Novartis AG Business Overview Table 129. Novartis AG Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Novartis AG Opioid Analgesics Product Portfolio Table 131. Novartis AG Recent Development Table 132. Johnson & Johnson Company Information Table 133. Johnson & Johnson Business Overview Table 134. Johnson & Johnson Opioid Analgesics Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Johnson & Johnson Opioid Analgesics Product Portfolio Table 136. Johnson & Johnson Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Opioid Analgesics Distributors List Table 140. Opioid Analgesics Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Opioid Analgesics Product Image Figure 2. Global Opioid Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Analgesics Sales (2021-2032) & (Tons) Figure 5. Global Opioid Analgesics Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Opioid Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Morphine Image Figure 9. Methadone Image Figure 10. OxyContin Image Figure 11. Vicodin Image Figure 12. Others Image Figure 13. Global Opioid Analgesics Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Opioid Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Opioid Analgesics Sales Market Share by Type (2021-2032) Figure 16. Global Opioid Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 17. Global Opioid Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Opioid Analgesics Revenue Market Share by Type (2021-2032) Figure 19. Surgical Pain Image Figure 20. Neuropathic Pain Image Figure 21. Cancer Pain Image Figure 22. Others Image Figure 23. Global Opioid Analgesics Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Opioid Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Opioid Analgesics Sales Market Share by Application (2021-2032) Figure 26. Global Opioid Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 27. Global Opioid Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Opioid Analgesics Revenue Market Share by Application (2021-2032) Figure 29. North America Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 30. North America Opioid Analgesics Sales Market Share by Country (2021-2032) Figure 31. U.S. Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Canada Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Mexico Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Europe Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Europe Opioid Analgesics Sales Market Share by Country (2021-2032) Figure 36. Germany Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 37. France Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 38. U.K. Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Italy Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Netherlands Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Asia Pacific Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Asia Pacific Opioid Analgesics Sales Market Share by Country (2021-2032) Figure 43. China Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Japan Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South Korea Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Southeast Asia Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 47. India Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Australia Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South America, Middle East and Africa Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 50. South America, Middle East and Africa Opioid Analgesics Sales Market Share by Country (2021-2032) Figure 51. Brazil Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 52. South Africa Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Saudi Arabia Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Turkey Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Argentina Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 56. UAE Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Egypt Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 58. Chile Opioid Analgesics Sales and Growth Rate (2021-2032) & (Tons) Figure 59. Global Opioid Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Opioid Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Opioid Analgesics Revenue (2021-2032) & (US$ Million) Figure 62. North America Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Opioid Analgesics Revenue (2021-2032) & (US$ Million) Figure 64. Europe Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Opioid Analgesics Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Opioid Analgesics Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Opioid Analgesics Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Opioid Analgesics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Methadone
  • OxyContin
  • Vicodin
  • Others
Applications
  • Surgical Pain
  • Neuropathic Pain
  • Cancer Pain
  • Others
Companies covered
  • Assertio Holdings, Inc
  • Bausch Health
  • Boehringer Ingelheim International GmbH
  • Endo International Plc
  • F. Hoffmann-La Roche AG
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • Abbott Laboratories
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Opioid Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Opioid Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Opioid Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Opioid Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Opioid Analgesics Market Dynamics
  1. 2.1 Opioid Analgesics Industry Trends
  2. 2.2 Opioid Analgesics Industry Drivers
  3. 2.3 Opioid Analgesics Industry Opportunities and Challenges
  4. 2.4 Opioid Analgesics Industry Restraints
3 Opioid Analgesics Market by Manufacturers
  1. 3.1 Global Opioid Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Opioid Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Opioid Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Opioid Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Opioid Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Opioid Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Analgesics Tier 1, Tier 2, and Tier 3
4 Opioid Analgesics Market by Type
  1. 4.1 Opioid Analgesics Type Introduction
  2. 4.1.1 Morphine
  3. 4.1.2 Methadone
  4. 4.1.3 OxyContin
  5. 4.1.4 Vicodin
  6. 4.1.5 Others
  7. 4.2 Global Opioid Analgesics Sales by Type
  8. 4.2.1 Global Opioid Analgesics Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Opioid Analgesics Sales by Type (2021-2032)
  10. 4.2.3 Global Opioid Analgesics Sales Market Share by Type (2021-2032)
  11. 4.3 Global Opioid Analgesics Revenue by Type
  12. 4.3.1 Global Opioid Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Opioid Analgesics Revenue by Type (2021-2032)
  14. 4.3.3 Global Opioid Analgesics Revenue Market Share by Type (2021-2032)
5 Opioid Analgesics Market by Application
  1. 5.1 Opioid Analgesics Application Introduction
  2. 5.1.1 Surgical Pain
  3. 5.1.2 Neuropathic Pain
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Others
  6. 5.2 Global Opioid Analgesics Sales by Application
  7. 5.2.1 Global Opioid Analgesics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Opioid Analgesics Sales by Application (2021-2032)
  9. 5.2.3 Global Opioid Analgesics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Opioid Analgesics Revenue by Application
  11. 5.3.1 Global Opioid Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Opioid Analgesics Revenue by Application (2021-2032)
  13. 5.3.3 Global Opioid Analgesics Revenue Market Share by Application (2021-2032)
6 Global Opioid Analgesics Sales by Region
  1. 6.1 Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Opioid Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Opioid Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Opioid Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Opioid Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Opioid Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Opioid Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Opioid Analgesics Revenue by Region
  1. 7.1 Global Opioid Analgesics Revenue by Region
  2. 7.1.1 Global Opioid Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Opioid Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Opioid Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Opioid Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Opioid Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Opioid Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Opioid Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Opioid Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Opioid Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Assertio Holdings, Inc
  2. 8.1.1 Assertio Holdings, Inc Company Information
  3. 8.1.2 Assertio Holdings, Inc Business Overview
  4. 8.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
  6. 8.1.5 Assertio Holdings, Inc Recent Developments
  7. 8.2 Bausch Health
  8. 8.2.1 Bausch Health Company Information
  9. 8.2.2 Bausch Health Business Overview
  10. 8.2.3 Bausch Health Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bausch Health Opioid Analgesics Product Portfolio
  12. 8.2.5 Bausch Health Recent Developments
  13. 8.3 Boehringer Ingelheim International GmbH
  14. 8.3.1 Boehringer Ingelheim International GmbH Company Information
  15. 8.3.2 Boehringer Ingelheim International GmbH Business Overview
  16. 8.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
  18. 8.3.5 Boehringer Ingelheim International GmbH Recent Developments
  19. 8.4 Endo International Plc
  20. 8.4.1 Endo International Plc Company Information
  21. 8.4.2 Endo International Plc Business Overview
  22. 8.4.3 Endo International Plc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Endo International Plc Opioid Analgesics Product Portfolio
  24. 8.4.5 Endo International Plc Recent Developments
  25. 8.5 F. Hoffmann-La Roche AG
  26. 8.5.1 F. Hoffmann-La Roche AG Company Information
  27. 8.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 8.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
  30. 8.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 8.6 Purdue Pharmaceuticals L.P.
  32. 8.6.1 Purdue Pharmaceuticals L.P. Company Information
  33. 8.6.2 Purdue Pharmaceuticals L.P. Business Overview
  34. 8.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
  36. 8.6.5 Purdue Pharmaceuticals L.P. Recent Developments
  37. 8.7 Sanofi S.A.
  38. 8.7.1 Sanofi S.A. Company Information
  39. 8.7.2 Sanofi S.A. Business Overview
  40. 8.7.3 Sanofi S.A. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
  42. 8.7.5 Sanofi S.A. Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Abbott Laboratories
  50. 8.9.1 Abbott Laboratories Company Information
  51. 8.9.2 Abbott Laboratories Business Overview
  52. 8.9.3 Abbott Laboratories Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
  54. 8.9.5 Abbott Laboratories Recent Developments
  55. 8.10 Bayer AG
  56. 8.10.1 Bayer AG Company Information
  57. 8.10.2 Bayer AG Business Overview
  58. 8.10.3 Bayer AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer AG Opioid Analgesics Product Portfolio
  60. 8.10.5 Bayer AG Recent Developments
  61. 8.11 GlaxoSmithKline plc
  62. 8.11.1 GlaxoSmithKline plc Company Information
  63. 8.11.2 GlaxoSmithKline plc Business Overview
  64. 8.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
  66. 8.11.5 GlaxoSmithKline plc Recent Developments
  67. 8.12 Pfizer Inc.
  68. 8.12.1 Pfizer Inc. Company Information
  69. 8.12.2 Pfizer Inc. Business Overview
  70. 8.12.3 Pfizer Inc. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
  72. 8.12.5 Pfizer Inc. Recent Developments
  73. 8.13 Novartis AG
  74. 8.13.1 Novartis AG Company Information
  75. 8.13.2 Novartis AG Business Overview
  76. 8.13.3 Novartis AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novartis AG Opioid Analgesics Product Portfolio
  78. 8.13.5 Novartis AG Recent Developments
  79. 8.14 Johnson & Johnson
  80. 8.14.1 Johnson & Johnson Company Information
  81. 8.14.2 Johnson & Johnson Business Overview
  82. 8.14.3 Johnson & Johnson Opioid Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
  84. 8.14.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Analgesics Value Chain Analysis
  2. 9.1.1 Opioid Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Analgesics Production Mode & Process
  6. 9.2 Opioid Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Analgesics Distributors
  9. 9.2.3 Opioid Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst